marker of choice

marker of choice

A lab parameter used to evaluate disease response to therapy and monitor for recurrence. Markers of choice include RNA for progression of HIV infection and CEA for recurrent of colorectal cancer.

marker of choice

A lab parameter used to evaluate disease response to therapy and monitor for recurrence; MOCs include RNA for progression of HIV infection and CEA for colorectal cancer
References in periodicals archive ?
3) Because of this, the medical community has yet to adopt any one marker as the acute kidney injury (AKI) marker of choice.
Hence in the present study RAPDs proved them to be the marker of choice for the detection of variants in different hybrid combination of chrysanthemum including parents and offspring and in marker assisted selection in chrysanthemum breeding programs.
Regardless, hs-CRP will probably continue to be the marker of choice until physicians understand which medications lower Lp-PLA2, and with it, risk.
Hence, it seems that SNPs are increasingly becoming the dominant marker of choice in the field of genetics (Gupta et al.
The preferred measurement the biological markers of pyridinolines are in twenty-four (24) hours urine collections Dpd is the bone marker of choice for bone resorption.
AFLP, also considered a random marker, generates more polymorphisms per PCR reaction for higher throughput; therefore, is replacing RAPD as the marker of choice for tagging traits and constructing genetic linkage maps.
Current evidence and the recommendations of the American Heart Association support CRP as the marker of choice among inflammatory markers, and high sensitivity CRP methods should be used.
There was a tendency to favor one pair of markers (the geresh was the marker of choice for a rising tone, while the tevir was the marker of choice for the falling tone) over the others.
Although S100 protein has been the marker of choice, its expression is focal and frequently negative in MPNST.
BNP is a widely used diagnostic test identified as the marker of choice for diagnosing and assessing the severity of heart failure.
CK-MB and cTn provide similar information, and we concur with the current guideline recommendation that cTn should represent the marker of choice to detect post-PCI myocardial necrosis, given higher specificity and sensitivity and the lack of incremental information provided by CK-MB, with CK-MB used when cTn is not available.